Heart; Functional Disturbance
4
0
2
1
Key Insights
Highlights
Success Rate
50% trial completion
Treatment Research
10 treatments under study, led by Blood Draws
Research Leaders
6 sponsors active, led by Norwegian University of Science and Technology
Related Conditions
Often studied with 8 related conditions
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
25.0%
1 terminated out of 4 trials
50.0%
-36.6% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (4)
Improving Exercise Capacity With a Tailored Physical Activity Intervention
The Protein Disrupted in Schizophrenia 1 (DISC1) as a Novel Biomarker for Cardiac Disease
Hand Injected Ventriculography vs. Power Injected Left Ventriculography
Motion Analysis and Assessment of Cardiac Function for Cardiac Images
Research Network
Common Treatments
- Blood Draws1
- Blood Sampling1
- Echocardiography1
- Exercise With Trainerize Application1
- Mri Scan1
Active Sponsors
- Norwegian University of Science and Technology1
- Far Eastern Memorial Hospital1
- St. Olavs Hospital1
- National Cancer Institute (NCI)1
- Loma Linda University1
Top Investigators
Far Eastern Memorial Hospital
Norwegian University of Science and Technology
Wake Forest Baptist Comprehensive Cancer Center
Loma Linda University Medical Center
Related Conditions
- Stage Iii Breast Cancer1
- Heart Diseases1
- Hodgkin Lymphoma1
- Quality Of Life1
- Non Hodgkin Lymphoma1